5-hydroxydecanoate and sb 216763

5-hydroxydecanoate has been researched along with sb 216763 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berdeaux, A; Chenoune, M; Couvreur, N; Ghaleh, B; Pons, S; Tissier, R; Waintraub, X1

Other Studies

1 other study(ies) available for 5-hydroxydecanoate and sb 216763

ArticleYear
The ceiling effect of pharmacological postconditioning with the phytoestrogen genistein is reversed by the GSK3beta inhibitor SB 216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione] through mitochondrial ATP-dependent potassium c
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Decanoic Acids; Estradiol; Genistein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Rate; Hydroxy Acids; Indoles; Ischemic Preconditioning, Myocardial; KATP Channels; Male; Maleimides; Mitochondria; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Proto-Oncogene Proteins c-akt; Rabbits

2009